BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients.

Stefan VerheyeAdrian WlodarczakPiero MontorsiJan TorzewskiJohan Bennett Michael HaudeGregory StarmerThomas BuckMarcus WiemerAmin A B NuruddinBryan P-Y YanMichael K-Y Lee

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)

BIOSOLVE-IV confirms the safety and performance of the Magmaris scaffold in a large population with excellent device and procedure success and a very good safety profile up to 12 months in a low-risk population.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
prognostic factors
minimally invasive
type diabetes
tissue engineering
patient reported outcomes
metabolic syndrome
skeletal muscle
weight loss
patient reported